Merck & Co., Inc. Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
Merck & Co., Inc. (MRK) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of -$85.00 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-08
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was -$85.00M, a 284.78% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$419.00M, a 252.92% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $63.00M, a 94.61% decline year-over-year.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $394.00M.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was $84.00M.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was -$449.00M.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was -$213.00M.
- Merck & Co., Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2008 was -$1.73B, a 610.94% decline from fiscal 2007.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$85.00M 10-Q · filed 2012-05-08 | -$504.00M derived: sum of 2 quarters · filed 2012-05-08 | -$441.00M derived: sum of 3 quarters · filed 2012-05-08 | -$47.00M derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2011-12-31 | -$419.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$356.00M derived: sum of 2 quarters · filed 2012-02-28 | $38.00M derived: sum of 3 quarters · filed 2012-02-28 | $84.00M 10-K · filed 2012-02-28 | |||
| 2011-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $457.00M derived: sum of 2 quarters · filed 2011-11-08 | $503.00M 10-Q · filed 2011-11-08 | $777.00M derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2011-06-30 | $394.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $440.00M 10-Q · filed 2011-08-08 | $714.00M derived: sum of 3 quarters · filed 2012-05-08 | $1.88B derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2011-03-31 | $46.00M 10-Q · filed 2012-05-08 | $320.00M derived: sum of 2 quarters · filed 2012-05-08 | $1.49B derived: sum of 3 quarters · filed 2012-05-08 | $402.00M derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2010-12-31 | $274.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.44B derived: sum of 2 quarters · filed 2012-02-28 | $356.00M derived: sum of 3 quarters · filed 2012-02-28 | -$449.00M 10-K · filed 2012-02-28 | |||
| 2010-09-30 | $1.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $82.00M derived: sum of 2 quarters · filed 2011-11-08 | -$723.00M 10-Q · filed 2011-11-08 | -$723.50M 10-Q · filed 2010-11-08 | -$815.10M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | -$1.09B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$1.89B 10-Q · filed 2011-08-08 | -$1.89B 10-Q · filed 2010-08-06 | -$1.98B derived: sum of 3 quarters · filed 2012-02-28 | -$2.11B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | -$805.00M 10-Q · filed 2011-05-09 | -$897.10M derived: sum of 2 quarters · filed 2012-02-28 | -$1.02B derived: sum of 3 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | -$92.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$217.10M derived: sum of 2 quarters · filed 2012-02-28 | -$213.00M 10-K · filed 2012-02-28 | -$212.60M 10-K · filed 2010-03-01 | |||
| 2009-09-30 | -$125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$120.90M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $4.10M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | -$1.73B 10-K · filed 2011-02-28 | -$1.73B 10-K · filed 2010-03-01 | |||||
| 2007-12-31 | $338.20M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |